On May 27, Piper Sandler lowered the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) to $81 from $110 while keeping an Overweight rating on the shares. The price target decrease followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback